Inhibitors | Comment | Organism | Structure |
---|---|---|---|
rosiglitazone | - |
Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | O35547 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hepatic stellate cell | - |
Rattus norvegicus | - |
liver | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + arachidonate + CoA | - |
Rattus norvegicus | AMP + diphosphate + arachidonoyl-CoA | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 74000, SDS-PAGE | Rattus norvegicus |
Synonyms | Comment | Organism |
---|---|---|
ACSL4 | - |
Rattus norvegicus |
long-chain acyl-CoA synthetase 4 | - |
Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Rattus norvegicus |
Organism | Comment | Expression |
---|---|---|
Rattus norvegicus | isoform ACSL4 is upregulated in activated hepatic stellate cells | up |
General Information | Comment | Organism |
---|---|---|
physiological function | upregulation of isoform ACSL4 is responsible for the increase in polyunsaturated fatty acid-triacylglycerol species during activation of hepatic stellate cells, which may serve to protect cells against a shortage of polyunsaturated fatty acids required for eicosanoid secretion | Rattus norvegicus |